Joshua A. Hill, MD
Associate Professor
Vaccine and Infectious Disease Division, Fred Hutch
Associate Professor
Clinical Research Division, Fred Hutch
Member
Immunotherapy Integrated Research Center (IIRC), Fred Hutch
Member
Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch
Dr. Joshua Hill is a physician who specializes in the treatment of infectious diseases in cancer patients, solid organ transplant patients and others with weakened immune systems. His research includes clinical trials of new medicines to prevent or treat infections in such patients. He is particularly interested in viral infections, such as human herpesvirus 6. Dr. Hill’s epidemiological research focuses on infections in immunocompromised hosts, including those receiving new therapies such as CAR T cells. Dr. Hill’s research is highly collaborative. He works closely with oncologists, pulmonologists, pathologists, molecular virologists and statisticians. He is conducting clinical trials on outpatient treatments for coronavirus at Fred Hutch’s COVID-19 Clinical Research Center.
Other Appointments & Affiliations
Attending Physician, Infectious Disease Service, Fred Hutchinson Cancer CenterAttending Physician, Infectious Disease Service
Fred Hutchinson Cancer Center
Associate Professor, Division of Allergy and Infectious Diseases
University of Washington
Education
Fellow, Division of Allergy and Infectious Diseases, University of Washington Medical Center, Seattle, 2012-2015
Fellow, Harvard School of Public Health, Boston, 2013
Resident, Internal Medicine Residency, Brigham and Women’s Hospital, Harvard, Boston, 2009-2012
MD, University of Texas Southwestern Medical Center, Dallas, 2009
BA, Liberal Arts Plan II Honors Program and Natural Sciences, Dean’s Scholars Program, University of Texas at Austin, 2005
Research Interests
Clinical trials of new therapies to prevent or treat infections in immunocompromised patients
Viral infections, such as human herpesvirus 6 (HHV-6), and infections in patients receiving immunotherapies such as CAR-T cells
Awards and Honors
George Santos Award for best clinical science article by a new investigator, American Society for Blood and Marrow Transplantation, 2012
Robert A. Good New Investigator Award, American Society for Blood and Marrow Transplantation, 2014
Joel Meyers Infectious Diseases Scholar, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 2014
NIH Clinical Loan Repayment Program Award, 2015
NIH/NIAID K23 Career Development Award, 2015
Caroline B. Hall Young Investigator Award, 9th International HHV-6 & 7 Conference, 2015
Amy Strelzer Manasevit Research Program Scholar Award, NMDP/ASBMT, 2018
Fialkow Scholar Award, Department of Medicine, University of Washington, 2021
Fellow, Infectious Diseases Society of America, 2021